| Bioactivity | P8RI (D-P8RI) is a biomimetic peptide of CD31 and a CD31 agonist. P8RI binds to the juxtamembrane amino acid sequence of the ectodomain of CD31, shows an immunosuppressive effect through restoration of the CD31 inhibitory pathway[1][2]. | ||||||
| Invitro | P8RI (D-P8RI) was designed as a retro-inverso peptide with all-D-amino acids allowing to maintain bioactivity and to confer resistance towards plasma proteases[1]. | ||||||
| Name | P8RI | ||||||
| CAS | 2147724-76-1 | ||||||
| Shortening | KWPALFVR | ||||||
| Formula | C51H77N13O9 | ||||||
| Molar Mass | 1016.24 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
P8RI
CAS: 2147724-76-1 F: C51H77N13O9 W: 1016.24
P8RI (D-P8RI) is a biomimetic peptide of CD31 and a CD31 agonist. P8RI binds to the juxtamembrane amino acid sequence of
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.